ZC3HDC3 inhibitors are a class of chemical compounds that specifically target the Zinc Finger C3H Domain-Containing Protein 3 (ZC3HDC3). ZC3HDC3 is a protein characterized by the presence of C3H-type zinc finger domains, which are known for binding RNA and DNA molecules. This protein is implicated in various cellular processes, including the regulation of gene expression, RNA processing, and signal transduction pathways. By inhibiting ZC3HDC3, these compounds interfere with its ability to interact with nucleic acids or other proteins, thereby modulating the pathways in which it is involved. Researchers employ ZC3HDC3 inhibitors to study the functional roles of this protein within the cell, helping to elucidate its contributions to cellular homeostasis, development, and response to environmental cues.
ZC3HDC3 inhibitors are designed to interact with specific domains of the protein, particularly the zinc finger motifs that facilitate its binding to RNA or DNA. These inhibitors may be small molecules that mimic the natural ligands of ZC3HDC3 or that occupy its nucleic acid binding sites, effectively blocking its normal interactions. Some inhibitors might induce conformational changes in the protein structure, reducing its stability or altering its localization within the cell. The development of these compounds often involves structure-based drug design techniques, utilizing information from crystallography or NMR studies to identify key interaction sites. By using ZC3HDC3 inhibitors in experimental models, scientists can observe the effects of disrupted protein function on gene expression patterns, RNA metabolism, and other cellular processes. This research advances the understanding of the molecular mechanisms governing protein-nucleic acid interactions and the regulation of gene expression in eukaryotic cells.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that affects various cellular processes and signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can influence various cellular pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor impacting the MAPK/ERK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor affecting protein synthesis and signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor influencing cellular signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor affecting signaling pathways. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker possibly influencing calcium-dependent pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatase activity affecting protein modification pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Modulates protein phosphatase activity influencing protein modification. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor. | ||||||